Advanced Lung Cancer Inflammation Index has Prognostic Impact in Stage I Non-Small Cell Lung Cancer: A Registry-Based Analysis of 934 Patients
ALI is an independent prognostic factor for OS in stage I NSCLC patients treated with stereotactic RT, but not in surgically treated patients. Incorporating ALI into prognostic models improved OS prediction, supporting its role as a simple biomarker in early-stage NSCLC.
Authors
- Anne Winther‐Larsen (ORCID: https://orcid.org/0000-0002-2763-595X)
- Ninna Aggerholm‐Pedersen (ORCID: https://orcid.org/0000-0002-6859-5296)
- Birgitte Sandfeld‐Paulsen (ORCID: https://orcid.org/0000-0001-9884-9165)
- Camilla Højbjerg Gregersen
Institutions
- Aalborg University Hospital (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Clinical Lung Cancer
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1016/j.cllc.2025.10.013
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00